The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Maintenance therapy with carfilzomib, pomalidomide, and dexamethasone (KPd) in high-risk myeloma patients (pts): A phase 2 study with a safety run-in.
 
Ajay K. Nooka
Honoraria - Adaptive Biotechnologies; Amgen; BeyondSpring Pharmaceuticals; Bristol-Myers Squibb/Celgene; Cellectar; Genzyme; GlaxoSmithKline; Janssen Oncology; Karyopharm Therapeutics; Oncopeptides; ONK Therapeutics; Pfizer; Secura Bio; Takeda
Consulting or Advisory Role - Adaptive Biotechnologies; Amgen; BeyondSpring Pharmaceuticals; Bristol-Myers Squibb; Cellectar; Genzyme; GlaxoSmithKline; Janssen Oncology; Karyopharm Therapeutics; Oncopeptides; ONK Therapeutics; Pfizer; Secura Bio; Takeda
Research Funding - Amgen (Inst); Arch Oncology (Inst); Bristol-Myers Squibb/Celgene (Inst); Cellectar (Inst); GlaxoSmithKline (Inst); Janssen Oncology (Inst); Pfizer (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - GlaxoSmithKline
 
Nisha S Joseph
Consulting or Advisory Role - GlaxoSmithKline; Janssen Biotech
Research Funding - Bristol Myers Squibb Foundation; Janssen Biotech; Novartis; Regeneron
 
Madhav V. Dhodapkar
Consulting or Advisory Role - Janssen Oncology; lava therapeutics; Roche/Genentech
 
Craig C. Hofmeister
Honoraria - Abbvie; Janssen Oncology
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; Oncopeptides
Research Funding - Bristol-Myers Squibb (Inst); Sanofi (Inst)
Patents, Royalties, Other Intellectual Property - Patent related to REC-2282 (formerly AR-42, NSC D736012)
 
Vikas Anand Gupta
No Relationships to Disclose
 
Joel S Andrews
No Relationships to Disclose
 
Charise Gleason
No Relationships to Disclose
 
Anuja A Sharma
No Relationships to Disclose
 
Bryan J Burton
No Relationships to Disclose
 
Quanta R Cato
No Relationships to Disclose
 
Ching Siong Tey
No Relationships to Disclose
 
Manali Rupji
No Relationships to Disclose
 
Yuan Liu
No Relationships to Disclose
 
Ian McFadden
Employment - Amgen
 
Rani Najdi
Employment - Amgen
 
Lawrence H Boise
No Relationships to Disclose
 
Jonathan L. Kaufman
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb/Celgene; Celgene; Genentech; Incyte; TG Therapeutics
Research Funding - Abbvie/Genentech (Inst); Amgen (Inst); BMS (Inst); Celgene (Inst); Fortis (Inst); Janssen (Inst); Merck (Inst); Sutro Biopharma (Inst)
 
Sagar Lonial
Stock and Other Ownership Interests - TG Therapeutics
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen Oncology; Merck; Novartis; Sanofi; Takeda
Research Funding - Bristol-Myers Squibb; Celgene; Takeda
Other Relationship - TG Therapeutics